The conversation covers the ethical battleground surrounding the destruction of embryos for stem cell harvesting, with Munson arguing that a 300-cell embryo is fundamentally different from a developing fetus. He outlines the promises of the technology, from growing replacement organs using a patient's own genetic material to treating Alzheimer's, Parkinson's, and spinal cord injuries. Art pushes the discussion further into designer humans, enhanced intelligence, and the creation of subservient beings.
Art and Munson also examine the inevitability of reproductive cloning, the failures observed in animal cloning experiments, and whether the United States risks falling behind Europe and Asia by restricting research. The program opens with listener reactions to a striking Japanese parking garage ghost video and a lively open lines segment on the merits of broadcasting in stereo.
Key Moments
Reproductive cloning is inevitable: Munson concedes that, unlike nuclear energy, cloning needs only know-how rather than huge machines, so once the technology is understood reproductive cloning becomes inevitable; rich, ego-driven buyers will pay and sellers will appear.
The promise of regenerative medicine: Munson lays out the upside of stem cell research: cures for diabetes, Alzheimer's, Parkinson's, Huntington's and spinal cord injuries like Christopher Reeve's, framed in biblical language as the blind being made to see and cripples to walk.
Growing your own replacement heart: Bell asks how stem cells would be obtained; Munson explains the only known source is destruction of a five-day embryo, but the payoff is a replacement organ grown from your own genetic material with no rejection - 'it's your heart.'
Stem cells and the aging process: Bell pushes Munson on what perfected stem cell engineering would mean for aging itself; Munson speculates that continuous renewal of organs could push the limits of human lifespan into unknown territory.
If America bans it, the world will not stop: Munson warns that refusing the technology would be judged a serious moral mistake by future generations, and that Britain, Japan, France, Israel and Australia will continue stem cell research with or without the United States.